Phase IIa trial assessing the tolerability of oral insulin [ORMD 0801] in patients with type 1 diabetes mellitus

Trial Profile

Phase IIa trial assessing the tolerability of oral insulin [ORMD 0801] in patients with type 1 diabetes mellitus

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Apr 2013

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Adverse reactions
  • Sponsors Oramed Pharmaceuticals
  • Most Recent Events

    • 29 Apr 2013 Results presented at the Global Technology Community Diabetes Summit 2013, according to an Oramed Pharmaceuticals media release.
    • 28 Jun 2010 Results reported at the 2010 Scientific Sessions of the American Diabetes Association (ADA), according to an Oramed Pharmaceuticals media release.
    • 22 Jul 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top